Alterations in reactivity to acetylcholine in myasthenia gravis and carcinomatous myopathy.
D000109:Acetylcholine / Q000494:pharmacology*; D000368:Aged; D001713:Biphenyl Compounds / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004491:Edrophonium / Q000494:pharmacology; D005260:Female; D005730:Ganglionic Blockers / Q000494:pharmacology; D006801:Humans; D007269:Injections, Intra-Arterial; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000503:physiopathology*; D009157:Myasthenia Gravis / Q000503:physiopathology*; D009369:Neoplasms / Q000150:complications*; D009388:Neostigmine / Q000494:pharmacology; D009431:Neural Conduction
D001713:Biphenyl Compounds; D002800:Cholinesterase Inhibitors; D005730:Ganglionic Blockers; D009388:Neostigmine; D004491:Edrophonium; D000109:Acetylcholine